Moderna’s newly approved mRNA flu vaccine marks a significant milestone, potentially establishing the company in the seasonal flu market. This advancement also highlights the promise of mRNA technology in tackling rapidly evolving diseases and even cancer.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More